<Answer xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="Answer.xsd">
	<Meta>
		<Attribution Url="http://www.mayoclinic.com">
			Content provided by MayoClinic.com
		</Attribution>
		<ContentType>
			Answer
		</ContentType>
		<CopyrightOwner DocID="MayoCopyright">
			33DF435C-58F5-47FE-B83E25C1B9EA9A15
		</CopyrightOwner>
		<DocID>
			AN01838
		</DocID>
		<OriginalURL>
			http://www.mayoclinic.com/health/acetyl-l-carnitine/AN01838
		</OriginalURL>
		<UpdateDate>
			2012-09-07
		</UpdateDate>
		<PublicationDate>
			2008-05-01
		</PublicationDate>
		<ControlWords>
			<Category MCVID="1000" Title="Age">
				<Keyword MCVID="1124" Title="Adult">
					<Keyword MCVID="1125" Title="19 to 44 younger" />
				</Keyword>
			</Category>
			<Category MCVID="1000" Title="Age">
				<Keyword MCVID="1124" Title="Adult">
					<Keyword MCVID="1126" Title="45 to 64 middle" />
				</Keyword>
			</Category>
			<Category MCVID="1001" Title="Diseases and conditions">
				<Keyword MCVID="1134" Title="Nervous system">
					<Keyword MCVID="2947" Title="Noninfectious inflammatory">
						<Keyword MCVID="2952" Title="Demyelinating disease">
							<Keyword MCVID="2955" Title="Multiple sclerosis" />
						</Keyword>
					</Keyword>
				</Keyword>
			</Category>
		</ControlWords>
		<ObjectID>
			10D40E65-E7FF-0DBD-1989C1E8EE4F9741
		</ObjectID>
		<MayoVersion>
			4
		</MayoVersion>
		<MetaKeywords>
			<MetaKeyword>
				acetyl-l-carnitine
			</MetaKeyword>
			<MetaKeyword>
				alc
			</MetaKeyword>
			<MetaKeyword>
				multiple sclerosis
			</MetaKeyword>
			<MetaKeyword>
				MS
			</MetaKeyword>
			<MetaKeyword>
				ms fatigue
			</MetaKeyword>
			<MetaKeyword>
				acetyl l carnitine
			</MetaKeyword>
			<MetaKeyword>
				l-carnitine
			</MetaKeyword>
			<MetaKeyword>
				levocarnitine
			</MetaKeyword>
		</MetaKeywords>
		<HasFlash>
			0
		</HasFlash>
		<Source />
		<TermsOfUse DocID="AM00021" />
	</Meta>
	<Body>
		<Section>
			<SectionHead />
			<HTML>
				&lt;p&gt;
Some research suggests that acetyl-L-carnitine can improve fatigue associated with multiple sclerosis (MS), although more study is needed. 
&lt;/p&gt;
&lt;p&gt;
Acetyl-L-carnitine is a form of L-carnitine, an amino acid that is found in nearly all cells of the body. L-carnitine plays a critical role in the production of energy from long-chain fatty acids. In addition, it increases the activity of certain nerve cells in the central nervous system. 
&lt;/p&gt;
&lt;p&gt;
Fatigue is a common symptom in people with multiple sclerosis. The cause isn&apos;t well understood. A study published in 2006 evaluated the benefit of supplementation with L-carnitine in people with MS-related fatigue who had low blood levels of L-carnitine. Study participants were given 3 to 6 grams of oral L-carnitine daily. Researchers reported a decrease in fatigue intensity in 65 percent of participants treated with immunosuppressive drugs, especially in those treated with cyclophosphamide and interferon beta. Another study published in 2004 showed that acetyl-L-carnitine seemed to improve fatigue in people with MS better than amantadine, a drug commonly used to treat MS-related fatigue. 
&lt;/p&gt;
&lt;p&gt;
However, problems with the design of these studies make it unclear whether acetyl-L-carnitine is truly effective at reducing MS-related fatigue. A recent systematic review published in 2012 concluded that there is still insufficient evidence that carnitine offers a therapeutic advantage over placebo or other medications. An ongoing larger scale randomized, placebo-controlled clinical trial expected to be completed in 2013 may answer some of these questions. 
&lt;/p&gt;
&lt;p&gt;
Although acetyl-L-carnitine generally has few or mild side effects, it can interfere with anticoagulants and other medications. So talk to your doctor before starting acetyl-L-carnitine or any dietary supplement. 
&lt;/p&gt;
			</HTML>
		</Section>
	</Body>
	<Title>
		Acetyl-L-carnitine: Can it relieve MS fatigue?
	</Title>
	<Abstract>
		Some research suggests that acetyl-L-carnitine may improve fatigue associated with multiple sclerosis.
	</Abstract>
	<Question>
		I&apos;ve read that the dietary supplement acetyl-L-carnitine may reduce fatigue in multiple sclerosis. Is this true?
	</Question>
	<QuestionFirstName>
		No name
	</QuestionFirstName>
	<QuestionState>
		No state given
	</QuestionState>
	<BenefitSummary />
	<RelatedLinksBox>
		<LinkItem ContentType="Answer" DocID="AN00564" LinkType="Internal" ObjectID="D2402B6B-5C7C-484F-8D1FD5DB29D11345" Title="Demyelinating disease: What causes it?" Url="http://www.mayoclinic.com/health/demyelinating-disease/AN00564" />
		<LinkItem ContentType="SlideShow" DocID="DS00549" LinkType="Internal" ObjectID="270140A4-A09B-4746-8BBE8E05B51FAB44" Title="Slide show: How genetic disorders are inherited" Url="http://www.mayoclinic.com/health/genetic-disorders/DS00549" />
		<LinkItem ContentType="TestProcedure" DocID="MY00982" LinkType="Internal" ObjectID="24F2CAC7-F2A4-B0E5-3F6BCF0A979CB03E" Title="Lumbar puncture (spinal tap)" Url="http://www.mayoclinic.com/health/lumbar-puncture/MY00982" />
		<LinkItem ContentType="Answer" DocID="AN01811" LinkType="Internal" ObjectID="E644F0FD-E7FF-0DBD-10A8A923CD123979" Title="Multiple sclerosis: Can it cause seizures?" Url="http://www.mayoclinic.com/health/multiple-sclerosis/AN01811" />
		<LinkItem ContentType="Answer" DocID="AN01894" LinkType="Internal" ObjectID="550D9F81-E7FF-0DBD-168904A516DF6B56" Title="Vitamin D and MS: Is there any connection?" Url="http://www.mayoclinic.com/health/vitamin-d-and-ms/AN01894" />
		<LinkItem ContentType="Disease" DocID="DS00188" LinkType="Internal" ObjectID="CEC491ED-C3B3-4B39-9E747386136032B4" Title="Multiple sclerosis" Url="http://www.mayoclinic.com/health/multiple-sclerosis/DS00188" />
	</RelatedLinksBox>
</Answer>
